Tscan therapeutics announces upcoming presentation at the jefferies global healthcare conference

Waltham, mass., may 30, 2024 (globe newswire) -- tscan therapeutics, inc. (nasdaq: tcrx), a clinical-stage biopharmaceutical company focused on the development of t cell receptor (tcr)-engineered t cell (tcr-t) therapies for the treatment of patients with cancer, today announced that the company will present at the jefferies global healthcare conference being held at the marriott marquis in new york, ny on wednesday, june 5, 2024 at 11:00 a.m. eastern time.
TCRX Ratings Summary
TCRX Quant Ranking